Target intelligence / Profile preview

Furin convertase enzyme (Furin)

Target
Furin
Molecular classification
Enzyme, Serine protease, Proprotein convertase
01

Overview

Furin is a calcium-dependent serine protease and a key member of the proprotein convertase family, classified as a subtilisin-like enzyme[1][4][7]. It catalyzes the proteolytic cleavage of a wide range of precursor proteins—such as hormones, growth factors, receptors, and viral glycoproteins—at paired basic amino acid motifs, usually at the Arg-X-Lys/Arg-Arg↓ site[1][4]. The enzyme is synthesized as an inactive zymogen with a prodomain that functions as an intramolecular chaperone and auto-inhibitor, which is cleaved during intracellular trafficking to the trans-Golgi network and endosomal compartments, where it becomes fully active[2][5]. Furin plays a pivotal role in fundamental physiological processes, but its dysregulation is linked to diseases such as cancer, diabetes, cardiovascular disease, and infections, notably facilitating the activation of viral proteins in pathogens like SARS-CoV-2 and HIV[1][3]. Therapeutic targeting of furin is a subject of active research, although the risk of broad physiological disruption is a challenge[1][2][5][7].

Other names
Paired basic amino acid cleaving enzyme (PACE)Proprotein convertase subtilisin/kexin type 3 (PCSK3)
02

Mechanism of action

Direct inhibition of proteolytic cleavage activity by binding to the active site or substrate-binding cleft Allosteric inhibition interfering with domain dynamics or substrate access

03

Biological functions

Proteolytic activation of precursor proteinsRegulation of secretory pathway protein maturationProtein processing in cell signalingActivation of viral glycoproteins
04

Disease associations

CancerInfection (including viral pathogenesis, e.g., SARS-CoV-2, HIV)Metabolic disorders (e.g., diabetes, obesity)Neurodegenerative diseasesCardiovascular disease
05

Safety considerations

Potential broad off-target effects due to furin’s essential role in processing multiple endogenous proteins[2][5].Disruption of normal hormonal and growth factor maturationPossible interference with physiological host defense mechanisms
06

Interacting drugs

There are investigational furin inhibitors (e.g., decanoyl-RVKR-chloromethylketone, peptide-based inhibitors)

1 more in the full profile.

07

Biomarkers

Furin expression levels in tumor tissue (potential prognostic marker in cancer)Circulating furin protein/activity in plasma (explored for infection and metabolic disease risk)

Beyond the preview

Go deeper on Furin convertase enzyme (Furin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Furin convertase enzyme (Furin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call